Elan Zanaflex Promos Imply Unsubstantiated Quality Of Life Benefit, FDA Says
Executive Summary
Elan Zanaflex promotional materials imply a quality of life benefit not substantiated by clinical trials for the anti-spasmodic agent, FDA's ad division said